Healthcare Veteran Lori Logan Promoted to NASCO CEO
"
Logan brings a breadth of healthcare leadership experience and a deep understanding of the healthcare market. Logan's experience spans across the healthcare industry delivering solutions to all healthcare constituents: payers, providers, employers, and consumers.
Key areas of her accomplishments include:
- Modernizing NASCO's 'core-chassis' of products and launching the industry's first accountable care solution focused on performance and settlement to ensure value-based care programs are brought to scale and are based on performance.
- Delivered care management solutions to the small primary care practices served through Athenahealth.
- Updated and brought to market a new population health platform leveraging the extensive Geneia Data Science Lab.
- Provided direct primary care services to employers focused on population health.
- Led the provider solutions business at TriZetto, providing leading revenue cycle management (RCM) solutions to over 30,000 provider practices, covering 250,000 providers, growing the business with a 21% revenue CAGR.
- Brought several national innovations to support transparency and local affordable healthcare through both Cigna Healthcare and UnitedHealthcare.
"Hallmarks of
About NASCO
NASCO, a wholly owned subsidiary of Blue Cross Blue Shield of Michigan, is empowering health plans to deliver market-leading products and achieve affordability by driving benefit innovation and accelerating speed to market. Born from the Blues, for the Blues, the company provides innovative healthcare technology for leading health plans across the nation, and it delivers the capabilities and develops the solutions that create healthier outcomes for healthier lives. Learn more at nasco.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/healthcare-veteran-lori-logan-promoted-to-nasco-ceo-302417150.html
SOURCE NASCO
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
- Syncron Wins Bronze Stevie® Award in 2026 International Business Awards®
- NEXTDC Receives Frost & Sullivan's 2026 Australia Competitive Strategy Leadership Recognition for Excellence in Data Center Services Innovation and Growth
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share